Prednisone Patent Expiration

Prednisone is Used for managing a variety of inflammatory and autoimmune conditions including rheumatoid arthritis and allergic reactions. It was first introduced by Schering Corp Sub Schering Plough Corp in its drug Meticorten on Approved Prior to Jan 1, 1982. Other drugs containing Prednisone are Deltasone, Rayos, Paracort, Prednisone. 63 different companies have introduced drugs containing Prednisone.


Prednisone Patents

Given below is the list of patents protecting Prednisone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rayos US8168218 Delayed release tablet with defined core geometry Jan 07, 2028 Horizon
Rayos US9504699 Delayed-release glucocorticoid treatment of rheumatoid disease Aug 03, 2027 Horizon
Rayos US8309124 Delayed release tablet with defined core geometry Apr 23, 2024

(Expired)

Horizon
Rayos US8394407 Delayed release tablet with defined core geometry Apr 23, 2024

(Expired)

Horizon
Rayos US9040085 Delayed release tablet with defined core geometry Apr 23, 2024

(Expired)

Horizon
Rayos US9186332 Delayed release tablet with defined core geometry Apr 23, 2024

(Expired)

Horizon
Rayos US6488960 Corticosteroid formulation Mar 14, 2020

(Expired)

Horizon
Rayos US6677326 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration Mar 14, 2020

(Expired)

Horizon



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Prednisone's patents.

Given below is the list recent legal activities going on the following patents of Prednisone.

Activity Date Patent Number
Patent litigations
11.5 yr surcharge- late pmt w/in 6 mo, Large Entity 24 May, 2024 US8309124(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 24 May, 2024 US8309124(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 23 May, 2024 US9504699
Payment of Maintenance Fee, 12th Year, Large Entity 24 Oct, 2023 US8168218(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 09 May, 2023 US9186332
Payment of Maintenance Fee, 8th Year, Large Entity 16 Nov, 2022 US9040085
Payment of Maintenance Fee, 8th Year, Large Entity 26 Aug, 2020 US8394407(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 29 May, 2020 US9504699
Payment of Maintenance Fee, 8th Year, Large Entity 21 Apr, 2020 US8309124(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 17 Oct, 2019 US8168218(Litigated)


Prednisone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Prednisone Generic API Manufacturers

Several generic applications have been filed for Prednisone. The first generic version for Prednisone was by Hikma Pharmaceuticals Usa Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Pointview Holdings Llc and was approved on Dec 5, 2023.

Given below is the list of companies who have filed for Prednisone generic, along with the locations of their manufacturing plants worldwide.